gadoteridol 0 558.68000 559.128 A non-ionic gadolinium chelate having a macrocyclic tetraamine framework. It is used as a paramagnetic contrast agent in magnetic resonance imaging (MRI). C17H29GdN4O7 C17H29N4O7.Gd CAS:120066-54-8 CHEBI:31643 DPNNNPAKRZOSMO-UHFFFAOYSA-K DrugBank:DB00597 GD-HP-DO 3A Gd-HPDO3A Gmelin:897397 InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 KEGG:D01137 Patent:EP292689 Patent:US4885363 Wikipedia:Gadoteridol [2,2',2''-{10-[2-(hydroxy-kappaO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl-kappa(4)N(1),N(4),N(7),N(10)}triacetato-kappaO(3-)]gadolinium [H][O]1C(C)C[N]23CC[N]45CC[N]67CC[N]8(CC2)CC(=O)[O-][Gd+3]13468([O-]C(=O)C5)[O-]C(=O)C7 chebi.owl chebi_ontology gadolinium 2,2',2''-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate gadolinium-HP-DO3A gadoteridol gadoteridol gadoteridolum obi.owl gadolinium coordination entity